On Friday, Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $83.62 which represents a decrease of $-0.40 or -0.48% from the prior close of $84.02. The stock opened at $84.33 ...

Boston Scientific's strong history, margins, and pipeline make it a buy despite other analysts' Hold rating, with 15% growth ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

Canaccord Genuity analyst William Plovanic has maintained their bullish stance on BSX stock, giving a Buy rating today. William Plovanic has ...

In a report released today, Michael Matson from Needham maintained a Hold rating on Boston Scientific (BSX – Research Report). The ...

Since rolling out its pulsed field ablation system for treating atrial fibrillation earlier this year, Boston Scientific has ...

WASHINGTON, D.C.—Boston Scientific’s long-awaited transcatheter aortic heart valve missed its mark in a head-to-head study aimed at bringing the implant to the U.S.—but the company believes ...

Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions ...

Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...

Boston! Known for its rich history, prestigious universities, and thriving tech scene, this city is more than just a picturesque walk along the Charles River; it’s a fertile ground where ...

Former Oregon Ducks star Payton Pritchard shows how invaluable he is to the Boston Celtics with clutch shooting. Payton ...

A Boston environmentalist and entrepreneur, has launched an institute dedicated to fostering research, supporting emerging scholars, and stimulating policy change in fields including AI, social media, ...